Inpatient continuous-infusion interleukin-2 in 788 patients with cancer the national biotherapy study group experience

A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

1987 • 2,769 citations

Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

1985 • 2,616 citations

Interleukin-2: Inception, Impact, and Implications

1988 • 2,166 citations

Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer

1987 • 1,224 citations

Comparison of Carbamazepine, Phenobarbital, Phenytoin, and Primidone in Partial and Secondarily Generalized Tonic–Clonic Seizures

1985 • 1,149 citations

Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients

1989 • 1,003 citations

The Neuropsychiatric Effects of Treatment with Interleukin-2 and Lymphokine-Activated Killer Cells

1987 • 456 citations

Interleukin-2 toxicity.

1991 • 450 citations

Metastatic Renal Cancer Treated with Interleukin-2 and Lymphokine-Activated Killer Cells

1988 • 353 citations

Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: analysis of toxicity and management guidelines.

1989 • 349 citations

Cardiorespiratory effects of immunotherapy with interleukin-2.

1989 • 246 citations

A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanoma.

1989 • 240 citations

New Approaches to the Immunotherapy of Cancer Using Interleukin-2

1988 • 202 citations

Effects of Interleukin-2 on Renal Function in Patients Receiving Immunotherapy for Advanced Cancer

1987 • 170 citations

Hematologic effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patients

1987 • 166 citations

Dermatologic Changes Associated With Interleukin 2 Administration

1987 • 142 citations

Effect of autolymphocyte therapy on survival and quality of life in patients with metastatic renal-cell carcinoma

1990 • 123 citations

Continuous interleukin-2 and lymphokine-activated killer cells for advanced cancer: a National Biotherapy Study Group trial.

1991 • 120 citations

Continuous interleukin-2 and tumor-infiltrating lymphocytes as treatment of advanced melanoma. A national biotherapy study group trial

1991 • 119 citations

The Hemodynamic Effects of Treatment with Interleukin-2 and Lymphokine-Activated Killer Cells

1988 • 118 citations

Nosocomial Sepsis Associated with Interleukin-2

1990 • 91 citations

Recombinant Interleukin-2 and Adoptive Immunotherapy Alternated With Dacarbazine Therapy in Melanoma: A National Biotherapy Study Group Trial

1990 • 71 citations

Renal, volume, and hormonal changes during therapeutic administration of recombinant interleukin-2 in man

1987 • 52 citations

Effects of interleukin-2 immunotherapy on renal function.

1988 • 50 citations

Treatment of metastatic renal cell carcinoma by continuous intravenous infusion of recombinant interleukin-2: a single-center phase II study.

1992 • 48 citations

Thrombocytopenia during immunotherapy with interleukin-2 by constant infusion

1990 • 45 citations

A New Regimen of Interleukin 2 and Lymphokine-Activated Killer Cells

1988 • 41 citations

Combination biotherapy utilizing interleukin-2 and alpha interferon in patients with advanced cancer: a National Biotherapy Study Group Trial.

1992 • 34 citations

Chemotherapy in combination with biomodulation: a 5-year experience with cyclophosphamide and interleukin-2.

1992 • 34 citations

Association of interleukin-2 therapy with staphylococcal bacteremia

1991 • 30 citations

Subcutaneous interleukin-2 and interferon-alpha 2b in patients with metastatic renal cell cancer: the German outpatient experience.

1990 • 29 citations

Continuous infusion interleukin-2 and tumor-derived activated cells as treatment of advanced solid tumors: a National Biotherapy Study Group Trial.

1991 • 22 citations

Continuous infusion of interleukin-2 and cyclophosphamide as treatment of advanced cancers: a National Biotherapy Study Group Trial.

1991 • 7 citations

Cited By (0)

Loading...